Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01611038 · ClinicalTrials.gov registry record · NA
Methylselenocysteine Effects on Circadian Rhythm
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01611038 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 100 participants.
The verdict
NCT01611038, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine if vitamin supplementation with a naturally occurring dietary amino acid called organic selenium (i.e., methylselenocysteine) can restore disruption of circadian rhythm in shift workers.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Methylselenocysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01611038
The ClinicalTrials.gov registry entry for NCT01611038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01611038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01611038 about?
NCT01611038 is a clinical study titled "Methylselenocysteine Effects on Circadian Rhythm". The primary objective of this study is to determine if vitamin supplementation with a naturally occurring dietary amino acid called organic selenium (i.e., methylselenocysteine) can restore disruption of circadian rhythm in shift workers.
What is the current status of trial NCT01611038?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2011-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01611038?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Methylselenocysteine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01611038?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.